KCM
DRIO icon

Kingdon Capital Management’s DarioHealth DRIO Stock Holding History

Kingdon Capital Management’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,250
Closed -$1.39M – 71
2021
Q2 		$1.39M Buy
+3,250
New +$1.24M 0.16% 61

Other funds holding DRIO

CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kingdon Capital Management's DRIO Position: Q3 2021 in Review

Kingdon Capital Management sold out of DarioHealth (DRIO) in Q3 2021, closing a stake of 3,250 shares — an estimated $1.39M sold.

Kingdon Capital Management first reported a position in DRIO in Q2 2021 and held it in 1 quarter. The position peaked at $1.39M in Q2 2021. 57 funds tracked by Wall St. Rank hold DRIO as of Q3 2021.

  • Kingdon Capital Management reported no remaining DarioHealth position as of Q3 2021 after selling out during the quarter.
  • Kingdon Capital Management sold 3,250 DarioHealth shares in Q3 2021, an estimated $1.39M.
  • Kingdon Capital Management first reported a position in DarioHealth in Q2 2021 and held it in 1 quarter.
  • Kingdon Capital Management's DarioHealth position peaked at $1.39M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held DarioHealth as of Q3 2021.

Based on Kingdon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.